Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
Zhuang Li, Chun‐Xia Yi, Saeed Katiraei, et al.
Gut (2017) Vol. 67, Iss. 7, pp. 1269-1279
Open Access | Times Cited: 547

Showing 26-50 of 547 citing articles:

Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition
Alessio Colombo, Rebecca Sadler, Gemma Llovera, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 227
Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue
Baoguo Li, Li Li, Min Li, et al.
Cell Reports (2019) Vol. 26, Iss. 10, pp. 2720-2737.e5
Open Access | Times Cited: 221
The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss
A. Aoun, Fatima Darwish, Natacha Hamod
Preventive Nutrition and Food Science (2020) Vol. 25, Iss. 2, pp. 113-123
Open Access | Times Cited: 219
Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome
Miranda Green, Karan Arora, Satya Prakash
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2890-2890
Open Access | Times Cited: 217
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 207
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases
Serena Coppola, Carmen Avagliano, Antonio Calignano, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 682-682
Open Access | Times Cited: 201
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Nikhil Aggarwal, Shohei Kitano, Ginette Ru Ying Puah, et al.
Chemical Reviews (2022) Vol. 123, Iss. 1, pp. 31-72
Open Access | Times Cited: 192
From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators
Hui Han, Bao Yi, Ruqing Zhong, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 187
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 186
Gut vagal sensory signaling regulates hippocampus function through multi-order pathways
Andrea N. Suarez, Ted M. Hsu, Clarissa M. Liu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut
Xiuli Zeng, Xuxuan Gao, Yu Peng, et al.
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 169
Contribution of macronutrients to obesity: implications for precision nutrition
Rodrigo San‐Cristobal, Santiago Navas‐Carretero, Miguel Ángel Martínez‐González, et al.
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 6, pp. 305-320
Closed Access | Times Cited: 164
Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial
Siew C. Ng, Zhilu Xu, Joyce Wing Yan Mak, et al.
Gut (2021) Vol. 71, Iss. 4, pp. 716-723
Closed Access | Times Cited: 154
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Huiqin Hou, Danfeng Chen, Kexin Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 225-235
Closed Access | Times Cited: 152
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Md. Mominur Rahman, Fahadul Islam, Md. Harun- Or-Rashid, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 151
Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein
Huiwen Xiao, Ming Cui, Yuan Li, et al.
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 149
Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
Tiphaine Le Roy, Emilie Moens de Hase, Matthias Van Hul, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 534-543
Open Access | Times Cited: 147
Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
Shumin Zhang, Jingwen Zhao, Fei Xie, et al.
Obesity Reviews (2021) Vol. 22, Iss. 11
Closed Access | Times Cited: 143
Design of synthetic human gut microbiome assembly and butyrate production
Ryan L. Clark, Bryce Connors, David Stevenson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 139
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
Zhilu Xu, Wei Jiang, Wenli Huang, et al.
Genes & Nutrition (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 135
Role of the gut–brain axis in energy and glucose metabolism
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129
The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
Michelle D. Pang, Gijs H. Goossens, Ellen E. Blaak
Frontiers in Nutrition (2021) Vol. 7
Open Access | Times Cited: 124
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers
Timothy A. Houtman, Henrik Eckermann, Hauke Smidt, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 115
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family
Jingjing Du, Peiwen Zhang, Jiang Luo, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 106

Scroll to top